We are live on ! Find out more
PL

Parkwood LLC Portfolio holdings

AUM $1.13B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+32.89%
3 Year Est. Return
+85.78%
5 Year Est. Return
+92.19%
10 Year Est. Return
+373.76%
AUM
$549M
AUM Growth
-$179M
Cap. Flow
+$11.4M
Cap. Flow %
2.08%
Top 10 Hldgs %
38.97%
Holding
186
New
26
Increased
38
Reduced
43
Closed
44

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$101M
2
BYND icon
Beyond Meat
BYND
+$68.6M
3
GH icon
Guardant Health
GH
+$37.3M
4
ATEC icon
Alphatec Holdings
ATEC
+$18.7M
5
WBD icon
Warner Bros
WBD
+$8.67M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.84M
2
CNH
CNH Industrial
CNH
+$7.32M
3
C icon
Citigroup
C
+$6.1M
4
LUMN icon
Lumen
LUMN
+$5.83M
5
JNJ icon
Johnson & Johnson
JNJ
+$5.33M

Sector Composition

Rank Sector Weight
1 Financials 16.29%
2 Healthcare 13.66%
3 Technology 12.65%
4 Energy 11.73%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
101
Netflix
NFLX
$299B
$542K 0.1%
+12,310
New +$453K
CHGG icon
102
Chegg
CHGG
$110M
$537K 0.1%
60,431
+6,557
+12% +$79.5K
ZS icon
103
Zscaler
ZS
$24.5B
$528K 0.1%
3,612
+241
+7% +$29.4K
ACI icon
104
Albertsons Companies
ACI
$5.62B
$507K 0.09%
+23,256
New +$484K
CARG icon
105
CarGurus
CARG
$3.27B
$490K 0.09%
21,631
-3,626
-14% -$68.6K
ETNB
106
DELISTED
89bio
ETNB
$446K 0.08%
+23,525
New +$413K
ACAD icon
107
Acadia Pharmaceuticals
ACAD
$4.43B
$444K 0.08%
18,535
+1,393
+8% +$31K
DOCU
108
DocuSign
DOCU
$10.5B
$442K 0.08%
8,645
+1,810
+26% +$95.9K
PD icon
109
PagerDuty
PD
$816M
$432K 0.08%
+19,218
New +$534K
CTKB icon
110
Cytek Biosciences
CTKB
$545M
$412K 0.08%
48,244
+17,332
+56% +$155K
UCB
111
United Community Banks
UCB
$4.24B
$404K 0.07%
16,155
REPX icon
112
Riley Exploration Permian
REPX
$744M
$397K 0.07%
11,113
JBIO
113
Jade Biosciences
JBIO
$1.2B
$392K 0.07%
652
-87
-12% -$55.6K
BIIB icon
114
Biogen
BIIB
$30B
$363K 0.07%
1,273
-97
-7% -$28.9K
VRNA
115
DELISTED
Verona Pharma
VRNA
$363K 0.07%
17,166
-1,712
-9% -$36.5K
KTOS icon
116
Kratos Defense & Security Solutions
KTOS
$8.74B
$351K 0.06%
+24,500
New +$332K
AM icon
117
Antero Midstream
AM
$10.4B
$314K 0.06%
27,103
LEGN icon
118
Legend Biotech
LEGN
$3.59B
$309K 0.06%
+4,479
New +$293K
VOR icon
119
Vor Biopharma
VOR
$1.15B
$228K 0.04%
3,697
+2,610
+240% +$238K
AR icon
120
Antero Resources
AR
$11.1B
$200K 0.04%
8,696
NGM
121
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$177K 0.03%
68,314
NVACR
122
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$120K 0.02%
1,000,000
KOD icon
123
Kodiak Sciences
KOD
$2.6B
$75K 0.01%
+10,887
New +$66.6K
JGGCR
124
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$75K 0.01%
500,000
CLINR
125
DELISTED
Clean Earth Acquisitions Corp. Right
CLINR
$65K 0.01%
500,000

Similar funds

Parkwood LLC's Q2 2023 Portfolio in Review

As of Q2 2023, Parkwood LLC held 186 positions worth $549M, down 25% from $728M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parkwood LLC's Q2 2023 filing shows 26 new, 38 increased, 43 reduced and 44 closed positions. Its largest new stake was Exact Sciences: 1,300,000 shares worth $1.33M. The largest sale was GE Aerospace, an estimated $9.84M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

  • Parkwood LLC's largest Q2 2023 buy was Exact Sciences: 1,300,000 shares worth $1.33M.
  • Parkwood LLC added most to Elevance Health in Q2 2023, an estimated $1.97M increase.
  • Parkwood LLC's biggest Q2 2023 reduction was GE Aerospace, cutting an estimated $9.84M.
  • Parkwood LLC fully exited CNH Industrial in Q2 2023, selling an estimated $7.32M.
  • Parkwood LLC's ten largest holdings make up 39% of its $549M portfolio in Q2 2023.
  • Parkwood LLC opened 26 new positions and closed 44 in Q2 2023.
  • Parkwood LLC's portfolio value fell 25% quarter-over-quarter to $549M.

Based on Parkwood LLC's 13F filing for Q2 2023, filed 14 Aug 2023.